Global Biosimilar Market - Opportunities & Forecast, 2020-2027

 

GMI Research market report focuses on providing an overview of the industry through detailed market segmentation. The report has information related to the overview and scope of the market followed by the key drivers, restraints, and emerging trends in the market. This report is especially designed to include both qualitative and quantitative aspects of the industry in each region and country included in the study.

List of Significant Manufacturers in the Biosimilar Market include:

·         Amgen Inc.

·         Novartis AG

·         Dr. Reddy’s Laboratories Ltd.

·         F. Hoffmann-La Roche Ltd.

·         Mylan N.V.

·         Sandoz International GmbH

·         Teva Pharmaceutical Industries Ltd.

·         Pfizer Inc.

·         Samsung Bioepis

·         LG Life Sciences

·         Biocon

Biosimilar Market Drivers and Restraints:

Biosimilar is majorly applied in medical, healthcare sectors, pharmaceuticals, and biotechnology. The primary factor boosting the growth of the biosimilar market includes cost-effectiveness, which is less than its original clinical product. Cost-effectiveness enables us to drive uptake of the biosimilar market by growing treatment. Its individual brand name identifies every biosimilar product, and it will vary from other biosimilar products. After the original product's expiration, there is a wide opportunity for a generic version of the biosimilar market. Biosimilar product is highly targeting to monoclonal antibodies (MAbs) development. Other important segments of this market, such as erythropoietin, human growth hormone, interferon, insulin. Biosimilar products are extremely sensitive to manufacturing changes. On the other hand, one of the potential threats of a biosimilar product is an antigen, and immunogenicity, to provoke the immunity of the human body.

Segmentation: Biosimilar Market

Biosimilar Market: By Types of Product

·         Human Growth Hormone

·         Granulocyte Colony-stimulating Factor (G-CSF)

·         Insulin

·         Interferon

·         Erythropoietin

·         Immunomodulators

·         Monoclonal antibodies

Biosimilar Market: By Application Type

·         Blood Disorders

·         Oncology

·         Growth Hormonal Deficiency

·         Chronic and Autoimmune Disease

·         Endocrinology

·         Nephrology

Biosimilar Market: By Region

·         North America

 

o   United States of America

o   Canada

 

·         Asia Pacific

 

o   China

o   Japan

o   India

o   Rest of APAC

 

·         Europe

 

o   United Kingdom

o   Germany

o   France

o   Spain

o   Rest of Europe

 

·         RoW

 

o   Brazil

o   South Africa

o   Saudi Arabia

o   UAE

o   Rest of the world (remaining countries of the LAMEA region)

 

About GMI Research

GMI Research is a market research and consulting firm which provides bespoke industry & market research to help businesses in making the toughest business decision. We know the significance of accurate data; that’s why our analyst uses a tailored methodology to study every market in detail because one size doesn’t fit all. We not only cover the traditional well-established market but also focuses on the niche market and markets in the emerging economies, where getting data and information is a challenge. This factor makes us pioneer in emerging market research space. Our syndicate reports cover multiple industries across various regions and countries.

Our in-depth market reports help propel your business with all the data, strategic inputs, and competitive intelligence to move ahead even in the most uncertain times. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research look forward to help businesses stay ahead of the curve.